BioLineRx Market Cap

BioLineRx has a market cap or net worth of 42.42 million as of May 13, 2025. Its market cap has decreased by -79.31% in one year.

Market Cap

42.42M

Enterprise Value

25.95M

Revenue

105.41M

Ranking

n/a

PE Ratio

n/a

Stock Price

1.90

Market Cap Chart

Since February 13, 2007, BioLineRx's market cap has increased from 163.03K to 42.42M, an increase of 25,920.20%. That is a compound annual growth rate of 35.61%.

Market Cap History

Date	Market Cap	% Change
May 13, 2025	40.19M	-53.02%
Dec 31, 2024	85.55M	-79.39%
Dec 31, 2023	415.08M	314.57%
Dec 29, 2022	100.12M	-67.59%
Dec 30, 2021	308.95M	60.58%
Dec 31, 2020	192.39M	108.80%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 31, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Teva Pharmaceutical Industries	73.61B
Danel (Adir Yeoshua)	2.35B
Kamada	1.39B
Bait Bakfar	1.15B
Novolog (Pharm-Up 1966)	779.55M
SofWave Medical	722.24M
Ilex Medical	680.80M
BrainsWay	586.43M

Market Cap Rankings